Gary E. Costley, Ph.D., Chairman
Gary E. Costley, Ph.D., is co-founder and managing director of C&G Capital and Management, LLC, which provides capital and executive management support to health, nutritional, and medical product companies. Previously, he served as Chairman and Chief Executive Officer of International Multifoods Corporation, a manufacturer and marketer of branded consumer food and food service products.
Earlier in his career, Dr. Costley served in numerous executive management positions at Kellogg Company, including most recently as President of Kellogg North America. He currently also serves on the Board of Directors for Covance Inc., The Principal Financial Group, Tiffany & Co., and Prestige Brand Holdings, Inc.
Hugo Braun is a partner and co-founder of North Coast Technology Investors, a Michigan-based venture capital firm with over $100 million under management that focuses on early stage investments in IT, advanced materials and life sciences. Prior to North Coast, Hugo worked in San Francisco co-managing BankAmerica’s venture capital portfolio. Hugo holds an M.S. in Management from the Sloan School at MIT and a B.A. in Economics from Yale University.
Roger D’Orazio is currently the Dealer Principal of D’Orazio Ford and the owner of Dora LLC, a single member owned REIT. He previously owned and operated Collision Revision, CR Coatings, CR Car Rental, CR Towing and CR Trucking & Logistics, prior to their sale in 2014. Roger was the founding Director of First Community Bank and in 2004 was named an Ernst & Young Entrepreneur of the Year.
Roger aspires to help build companies whereby the employees and investors prosper by making products the world needs. He enjoys golfing and fishing, and spending time with his wife Elaine, their four children and nine grandchildren.
Angela Harris, J.D.
Angela Harris is principal and founder of ACH Consulting, LLC, serving corporate and nonprofit clients as an organizational strategist, board and executive coach, and brand ambassador. Prior to founding the firm in 2004, she served as Vice President and General Counsel at Reading Industrial Maintenance, Inc. and as the Director of Government Affairs at the American Frozen Food Institute in Washington, D.C.
Angela has extensive board governance experience including service as National President of Alpha Chi Omega Fraternity, Inc. and as board chair of the Women’s Center of Southeastern Michigan. She holds a Juris Doctor from George Washington University Law School and a B.A. in Psychology and Organizational Development from Purdue University.
Dave Peralta has served as the company’s Chief Executive Officer since 2013. He joined BlueWillow (then known as NanoBio Corporation) in 2006 and served as the company’s Chief Operating and Financial Officer through 2012. Dave was promoted to Chief Executive Officer in 2013 and has directed the company’s strategic shift towards use of its nanotechnology platform for the development of novel topical antiseptic products and intranasal vaccines & immunotherapy applications.
Prior to joining BlueWillow, Dave served as Chief Financial Officer for Arbortext, Inc., a venture-backed enterprise software company, up through the company’s acquisition in 2005. Before joining Arbortext, Dave served for six years as the Chief Financial Officer of Mechanical Dynamics, a publicly-held software company, where he directed all finance and investor relations activities during the company’s initial public offering and up through the sale of the company in 2002.
Dave earned a BBA, with distinction, from the University of Michigan Ross School of Business. He currently resides in Northville, Michigan, with his wife Rose and their four children.
David M. Stout
David M. Stout has served as a top-level pharmaceutical executive, both nationally and internationally, for the past 30 years. His most recent position was President of Pharmaceutical Operations for GlaxoSmithKline Pharmaceuticals. In this capacity, he led all global commercial activities, global manufacturing, and all vaccine-related activities for the company, including research and development. Additionally, Mr. Stout directed the corporate pandemic flu preparedness program – an international effort that supports governments, health authorities, and company employees around the world in responding to a global influenza pandemic.
Prior to his tenure at GSK, Mr. Stout served as President of SmithKline Beecham’s North American pharmaceutical business, launching two major products and two sales force expansions. His pharmaceutical career began at Warner-Lambert Pharmaceutical Company and continued at Schering-Plough Corporation, where he served in numerous positions, including President of Schering Laboratories.
Phil Wilmington is vice chairman at Workday, and focuses on building and expanding relationships with global customers, prospective customers, and strategic business partners, in addition to helping mentor the next generation of Workday sales leaders. Previously, from 2015 to 2018, Phil served as co-president.
Phil has more than 30 years’ experience in the enterprise software industry, most of which has been in executive management and leading customer-focused field operations. Prior to joining Workday, Phil served as president and chief operating officer at Tidemark Systems. Before Tidemark, he was president and CEO at OutlookSoft. Phil also previously served as co-president at PeopleSoft and held senior leadership positions at TriNet and Tesseract.
Phil holds a bachelor’s degree in marketing and business administration from Bradley University, and is a former member of the University’s board of trustees.